Wang, H., Feng, X., Han, P., Lei, Y., Xia, Y., Tian, D., & Yan, W. (2019). The JAK inhibitor tofacitinib ameliorates immune-mediated liver injury in mice. Mol Med Rep.
Chicago-стиль цитированияWang, Han, Xinxia Feng, Ping Han, Yu Lei, Yujia Xia, Dean Tian, and Wei Yan. "The JAK Inhibitor Tofacitinib Ameliorates Immune-mediated Liver Injury in Mice." Mol Med Rep 2019.
MLA-цитированиеWang, Han, et al. "The JAK Inhibitor Tofacitinib Ameliorates Immune-mediated Liver Injury in Mice." Mol Med Rep 2019.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.